Covidien and Allergan Extend Agreement to Promote LAP-BAND® Adjustable Gastric Banding System

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan's LAP-BANDR System, the top-selling adjustable gastric band for bariatric surgery, in the United States. (Photo: Business Wire)

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan's LAP-BANDR System, the top-selling adjustable gastric band for bariatric surgery, in the United States. (Photo: Business Wire)

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan's LAP-BANDR System, the top-selling adjustable gastric band for bariatric surgery, in the United States. (Photo: Business Wire)